EU approves sale of new Alzheimer’s drug, with conditionsLeqembi is the brand name of an active substance called lecanemabThe EMA “concluded that the benefits of this medicine outweighed the risks”By AFP · 16 April 2025
King Abdulaziz University launches Saudi Arabia’s first PET/MRI Alzheimer’s diagnostic serviceBy Arab News · 19 December 2024
